DNA demethylation of CD40L in CD4+ T cells from women with systemic sclerosis: A possible explanation for female susceptibility

Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not wel...

Full description

Saved in:
Bibliographic Details
Published inArthritis & rheumatology (Hoboken, N.J.) Vol. 64; no. 7; pp. 2338 - 2345
Main Authors Lian, XiaoRi, Xiao, Rong, Hu, Xinhong, Kanekura, Takuro, Jiang, HongYan, Li, YaPing, Wang, YaoYao, Yang, Yan, Zhao, Ming, Lu, QianJin
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.07.2012
Wiley
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up‐regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. Methods CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real‐time reverse transcription–polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. Results CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Conclusion Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc.
AbstractList Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. Methods CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. Results CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Conclusion Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc. [PUBLICATION ABSTRACT]
Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. Methods CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. Results CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Conclusion Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc.
Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc.
Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc.OBJECTIVESystemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc.CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region.METHODSCD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region.CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated.RESULTSCD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated.Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc.CONCLUSIONDemethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc.
Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up‐regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc. Methods CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real‐time reverse transcription–polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region. Results CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated. Conclusion Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc.
Author Lu, QianJin
Lian, XiaoRi
Wang, YaoYao
Zhao, Ming
Hu, Xinhong
Yang, Yan
Jiang, HongYan
Xiao, Rong
Li, YaPing
Kanekura, Takuro
Author_xml – sequence: 1
  givenname: XiaoRi
  surname: Lian
  fullname: Lian, XiaoRi
  organization: Second Xiangya Hospital and Central South University, Changsha, China
– sequence: 2
  givenname: Rong
  surname: Xiao
  fullname: Xiao, Rong
  email: xiaorong65@yahoo.com.cn
  organization: Second Xiangya Hospital and Central South University, Changsha, China
– sequence: 3
  givenname: Xinhong
  surname: Hu
  fullname: Hu, Xinhong
  organization: Second Xiangya Hospital and Central South University, Changsha, China
– sequence: 4
  givenname: Takuro
  surname: Kanekura
  fullname: Kanekura, Takuro
  organization: Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan
– sequence: 5
  givenname: HongYan
  surname: Jiang
  fullname: Jiang, HongYan
  organization: Second Xiangya Hospital and Central South University, Changsha, China
– sequence: 6
  givenname: YaPing
  surname: Li
  fullname: Li, YaPing
  organization: Second Xiangya Hospital and Central South University, Changsha, China
– sequence: 7
  givenname: YaoYao
  surname: Wang
  fullname: Wang, YaoYao
  organization: Second Xiangya Hospital and Central South University, Changsha, China
– sequence: 8
  givenname: Yan
  surname: Yang
  fullname: Yang, Yan
  organization: Second Xiangya Hospital and Central South University, Changsha, China
– sequence: 9
  givenname: Ming
  surname: Zhao
  fullname: Zhao, Ming
  organization: Second Xiangya Hospital, Central South University, and Hunan Key Laboratory of Medical Epigenomics, Changsha, China
– sequence: 10
  givenname: QianJin
  surname: Lu
  fullname: Lu, QianJin
  organization: Second Xiangya Hospital and Central South University, Changsha, China
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26177047$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/22231486$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1rFDEUhoNU7LZ64R-QgAgWmTZfM9np3TLVKi4VZLXiTcjMntDUzGRNZtnOVf-62S-FoniV5PC8L-ecvEfooPMdIPScklNKCDvToT_lgsviERrRnJUZoZweoBEhRGQ8L-khOorxNj0Zz_kTdMgY41SMixG6v7ia4Dm00N8MTvfWd9gbXF0IMsW2W1_e4BluwLmITfAtXvkWOryy_Q2OQ-yhtQ2OjYPgo43neIIXPkZbO8Bwt3C623oaH7CBVqdyXMYGFr2trbP98BQ9NtpFeLY7j9GXd29n1fts-unyQzWZZo3IRZHNpeCsrkWdl4bMoebjojam5loWOTBm8oLTeakZ0VKKUmsKvCjTsEBoAyUv-TF6vfVdBP9zCbFXrY3rsXQHfhkVzbkYc8mJ-D9KGBvzclyShL58gN76ZejSIMmQSkpTNzJRL3bUsm5hrhbBtjoMav8LCXi1A3RstDNBd42Nf7gi-ZCN0dmWa9K2YwCjGttvFtwHbV3qTK3zoFIe1CYPSXHyQLE3_Ru7c19ZB8O_QTX5PNsrsq3CpiDc_Vbo8EMVkstcXV9dqq_X7Pu3j5VQFf8FijvRKQ
CODEN ARHEAW
CitedBy_id crossref_primary_10_1038_s41584_020_0470_9
crossref_primary_10_1038_nrd_2016_185
crossref_primary_10_1186_s13148_023_01445_5
crossref_primary_10_1016_j_jaut_2017_05_004
crossref_primary_10_1186_1868_7083_6_25
crossref_primary_10_1038_s41392_024_01929_7
crossref_primary_10_1053_j_seminhematol_2013_03_022
crossref_primary_10_1038_nrrheum_2017_220
crossref_primary_10_1016_j_tig_2020_06_016
crossref_primary_10_1111_1756_185X_13175
crossref_primary_10_3389_fimmu_2018_03112
crossref_primary_10_1016_j_jbspin_2014_03_004
crossref_primary_10_1016_j_jaut_2014_05_001
crossref_primary_10_1007_s00281_015_0507_3
crossref_primary_10_1007_s12016_013_8392_9
crossref_primary_10_1177_0961203320965690
crossref_primary_10_1093_rheumatology_keu155
crossref_primary_10_1016_j_jaut_2016_02_011
crossref_primary_10_1038_nrrheum_2014_128
crossref_primary_10_1016_j_clim_2012_07_006
crossref_primary_10_1016_j_biocel_2015_06_004
crossref_primary_10_2217_ijr_13_20
crossref_primary_10_1111_exd_14986
crossref_primary_10_23868_gc120579
crossref_primary_10_1016_j_healun_2016_02_007
crossref_primary_10_1155_2018_7342472
crossref_primary_10_1016_j_trsl_2018_08_001
crossref_primary_10_1177_1759720X20918456
crossref_primary_10_1016_j_heliyon_2024_e32366
crossref_primary_10_1038_gene_2014_44
crossref_primary_10_1016_j_clim_2015_03_006
crossref_primary_10_3390_biomedicines10123030
crossref_primary_10_1111_exd_12673
crossref_primary_10_1186_s13075_022_02741_w
crossref_primary_10_3389_fimmu_2019_02305
crossref_primary_10_1007_s11926_017_0685_1
crossref_primary_10_1016_j_berh_2017_09_006
crossref_primary_10_1016_j_autrev_2015_05_008
crossref_primary_10_1007_s00281_015_0504_6
crossref_primary_10_1126_sciadv_adn6537
crossref_primary_10_1159_000457944
crossref_primary_10_1007_s11926_019_0877_y
crossref_primary_10_5301_jsrd_5000209
crossref_primary_10_2147_IJGM_S356877
crossref_primary_10_1002_wrna_70003
crossref_primary_10_1111_sji_12121
crossref_primary_10_1016_j_clim_2018_03_011
crossref_primary_10_1136_annrheumdis_2011_201246
crossref_primary_10_7759_cureus_35593
crossref_primary_10_1084_jem_20211487
crossref_primary_10_3109_08916934_2015_1134511
crossref_primary_10_3389_fimmu_2018_02998
crossref_primary_10_1177_2397198319855872
crossref_primary_10_1155_2020_4286047
crossref_primary_10_1586_1744666X_2015_994507
crossref_primary_10_1016_j_autrev_2016_01_016
crossref_primary_10_1016_j_biocel_2015_05_023
crossref_primary_10_1007_s12016_016_8534_y
crossref_primary_10_1007_s10067_020_05255_5
crossref_primary_10_1038_nrrheum_2017_147
crossref_primary_10_3389_fimmu_2022_921765
crossref_primary_10_1016_j_clim_2012_01_017
crossref_primary_10_1016_j_rhum_2014_03_001
crossref_primary_10_1111_apt_14324
crossref_primary_10_1111_eci_12899
crossref_primary_10_1038_s41584_021_00683_2
crossref_primary_10_1111_exd_12767
crossref_primary_10_3390_cells12192376
crossref_primary_10_2217_epi_2016_0096
crossref_primary_10_1136_annrheumdis_2012_202742
crossref_primary_10_1186_s13073_020_00779_6
crossref_primary_10_1007_s12016_022_08956_8
crossref_primary_10_1016_j_mam_2016_10_001
crossref_primary_10_1080_09546634_2018_1473550
crossref_primary_10_1177_2397198318758221
crossref_primary_10_1016_j_clim_2013_06_006
crossref_primary_10_1007_s10238_019_00568_5
crossref_primary_10_1111_1346_8138_13185
crossref_primary_10_1016_j_autrev_2018_11_001
crossref_primary_10_1007_s10620_018_5072_x
crossref_primary_10_1007_s12016_024_09003_4
crossref_primary_10_1016_j_jaut_2016_06_020
crossref_primary_10_1007_s00296_023_05446_8
crossref_primary_10_3389_fgene_2015_00022
crossref_primary_10_3389_fimmu_2018_00478
crossref_primary_10_1016_j_biopha_2016_12_072
crossref_primary_10_3389_fgene_2014_00438
crossref_primary_10_1016_j_jaut_2013_01_010
crossref_primary_10_1186_s13148_019_0632_2
crossref_primary_10_1016_j_jaut_2013_01_012
crossref_primary_10_1038_nrrheum_2014_218
crossref_primary_10_3390_diagnostics14060652
crossref_primary_10_1111_bph_14783
crossref_primary_10_1111_exd_12900
crossref_primary_10_1007_s00281_017_0621_5
crossref_primary_10_1038_s41577_024_00996_9
crossref_primary_10_3389_fimmu_2023_1298665
crossref_primary_10_1111_1346_8138_13221
crossref_primary_10_1016_j_humimm_2018_01_003
Cites_doi 10.1038/ni0901-777
10.1093/jn/132.8.2401S
10.1002/eji.200324088
10.4049/jimmunol.174.10.6212
10.1016/j.jaut.2009.03.007
10.1016/j.autrev.2011.04.013
10.4049/jimmunol.168.7.3649
10.1002/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F
10.1136/ard.2007.073387
10.1002/art.23994
10.4049/jimmunol.172.6.3652
10.2741/1842
10.1080/03009740902758875
10.1016/j.jaut.2009.12.006
10.1002/art.10234
10.1038/sj.onc.1205609
10.1126/science.1136352
10.3109/08820130009062292
10.1016/j.semarthrit.2007.10.010
10.4049/jimmunol.179.9.6352
10.1016/j.it.2011.02.004
10.1080/08916930400002386
10.1016/j.autrev.2011.04.016
10.1007/s00018-003-3121-9
10.1146/annurev.iy.12.040194.004313
10.1006/jaut.2000.0387
10.1038/190372a0
10.1385/IR:27:2-3:185
ContentType Journal Article
Copyright Copyright © 2012 by the American College of Rheumatology
2015 INIST-CNRS
Copyright © 2012 by the American College of Rheumatology.
Copyright_xml – notice: Copyright © 2012 by the American College of Rheumatology
– notice: 2015 INIST-CNRS
– notice: Copyright © 2012 by the American College of Rheumatology.
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7QP
7T5
7TM
7U7
C1K
H94
K9.
7X8
DOI 10.1002/art.34376
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Nucleic Acids Abstracts
Toxicology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Toxicology Abstracts
Bacteriology Abstracts (Microbiology B)
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Calcium & Calcified Tissue Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList Toxicology Abstracts
Nucleic Acids Abstracts
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1529-0131
2326-5205
EndPage 2345
ExternalDocumentID 3277941551
22231486
26177047
10_1002_art_34376
ART34376
ark_67375_WNG_VW2ZXKC4_C
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Ministry of Science and Technology of the People's Republic of China
  funderid: International S&T Cooperation Project 2008DFA31980
– fundername: National Natural Science Foundation of China
  funderid: 30972662
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
10A
1CY
1KJ
1L6
1OB
1OC
1ZS
23N
24P
31~
33P
3O-
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52W
52X
53G
5GY
5RE
66C
6J9
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEVG
AAHHS
AAKAS
AANLZ
AAQQT
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBTR
ADEOM
ADIZJ
ADMGS
ADOZA
ADZCM
ADZOD
AEEZP
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZFZN
BDRZF
BROTX
BRXPI
BSCLL
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J5H
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
M65
MEWTI
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NNB
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q11
QB0
QRW
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RXW
RYL
SAMSI
SJN
SUPJJ
SV3
TAE
TEORI
TWZ
UB1
V2E
V8K
V9Y
VH1
W8V
WH7
WIB
WIH
WIJ
WIK
WIN
WJL
WOW
WQJ
WRC
WUP
WXI
WXSBR
X6Y
X7M
XG1
XPP
XV2
YFH
YOC
ZGI
ZXP
ZZTAW
~IA
~WT
AAHQN
AAIPD
AAMNL
AANHP
AAYCA
ACRPL
ACYXJ
ADNMO
AFWVQ
AAFWJ
AAYXX
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
0R~
3SF
52U
52V
5VS
7QL
7QP
7T5
7TM
7U7
AAESR
AASGY
ABLJU
ABPVW
ACGFS
ACGOF
ACIWK
ACPRK
ADBBV
ADKYN
ADXAS
ADZMN
AENEX
AEYWJ
AFRAH
AHMBA
ALAGY
ALVPJ
AZVAB
BFHJK
BHBCM
BMXJE
C1K
DIK
FUBAC
H94
K9.
KBYEO
NF~
O66
O9-
PQQKQ
WBKPD
WHWMO
WOHZO
WVDHM
7X8
ID FETCH-LOGICAL-c4546-d7432bb4b59f0deb386bffb3a765e22f5631d9a20a7749aa1e369235e01ce9393
IEDL.DBID DR2
ISSN 0004-3591
2326-5191
1529-0131
IngestDate Fri Jul 11 08:52:37 EDT 2025
Thu Jul 10 23:58:03 EDT 2025
Mon Jun 30 10:15:58 EDT 2025
Thu Apr 03 07:01:51 EDT 2025
Mon Jul 21 09:15:39 EDT 2025
Tue Jul 01 01:05:19 EDT 2025
Thu Apr 24 22:53:55 EDT 2025
Wed Jan 22 16:29:43 EST 2025
Wed Oct 30 09:51:35 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Human
Immunopathology
Connective tissue disease
Skin disease
Rheumatology
Autoimmune disease
Immunological investigation
DNA
Systemic disease
T-Lymphocyte
Female
Woman
Scleroderma
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
Copyright © 2012 by the American College of Rheumatology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4546-d7432bb4b59f0deb386bffb3a765e22f5631d9a20a7749aa1e369235e01ce9393
Notes ArticleID:ART34376
istex:8E3E5CBB3811653E028167D1F476974796BF1230
Ministry of Science and Technology of the People's Republic of China - No. International S&T Cooperation Project 2008DFA31980
ark:/67375/WNG-VW2ZXKC4-C
National Natural Science Foundation of China - No. 30972662
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 22231486
PQID 1517117747
PQPubID 946334
PageCount 8
ParticipantIDs proquest_miscellaneous_1534837304
proquest_miscellaneous_1022839890
proquest_journals_1517117747
pubmed_primary_22231486
pascalfrancis_primary_26177047
crossref_citationtrail_10_1002_art_34376
crossref_primary_10_1002_art_34376
wiley_primary_10_1002_art_34376_ART34376
istex_primary_ark_67375_WNG_VW2ZXKC4_C
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2012
PublicationDateYYYYMMDD 2012-07-01
PublicationDate_xml – month: 07
  year: 2012
  text: July 2012
PublicationDecade 2010
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: Hoboken , NJ
– name: United States
– name: Atlanta
PublicationTitle Arthritis & rheumatology (Hoboken, N.J.)
PublicationTitleAlternate Arthritis & Rheumatism
PublicationYear 2012
Publisher Wiley Subscription Services, Inc., A Wiley Company
Wiley
Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
– name: Wiley
– name: Wiley Subscription Services, Inc
References Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172: 3652-61.
Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B, et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007; 179: 6352-8.
Fukasawa C, Kawaguchi Y, Harigai M, Sugiura T, Takagi K, Kawamoto M, et al. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts. Eur J Immunol 2003; 33: 2792-800.
Sakkas LI, Xu B, Arlett CM, Lu S, Jimenez SA, Platsoucas CD. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002; 168: 3649-59.
Lu Q, Kaplan M, Ray D, Ray D, Zacharek S, Gutsch D, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1282-91.
Komura K, Fujimoto M, Yanaba K, Matsushita T, Matsushita Y, Horikawa M, et al. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse. Ann Rheum Dis 2008; 67: 867-72.
Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 2007; 315: 1141-3.
Lyon MF. Gene action in the X-chromosome of the mouse (mus musculus L.). Nature 1961; 190: 372-3.
Singer-Sam J, Riggs AD. X chromosome inactivation and DNA methylation. EXS 1993; 64: 358-84.
Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-6.
Chang SC, Tucker T, Thorogood NP, Brown CJ. Mechanisms of X-chromosome inactivation. Front Biosci 2006; 11: 852-66.
Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33: 3-11.
Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev 2011; 10: 641-6.
Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777-80.
Richardson B. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 2002; 132: 2401-5.
Chow JC, Brown CJ. Forming facultative heterochromatin: silencing of an X chromosome in mammalian females. Cell Mol Life Sci 2003; 60: 2586-603.
Robertson KD. DNA methylation and chromatin: unraveling the tangled web. Oncogene 2002; 21: 5361-79.
Valentini G, Romano MF, Naclerio C, Bisogni R, Lamberti A, Turco MC, et al. Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients. J Autoimmun 2000; 15: 61-6.
Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus inducing drugs. J Immunol 2005; 174: 6212-9.
Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881-922.
Cron RQ. CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res 2003; 27: 185-202.
Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME. The immunobiology of systemic sclerosis. Semin Arthritis Rheum 2008; 38: 132-60.
Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004; 37: 457-67.
Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009; 38: 369-74.
Cerutti A, Puga I, Cols M. Innate control of B cell responses. Trends Immunol 2011; 32: 202-11.
Kawai M, Masuda A, Kuwana M. A CD40-CD154 interaction in tissue fibrosis. Arthritis Rheum 2008; 58: 3562-73.
Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, et al. B cells in systemic sclerosis: a possible target for therapy. Autoimmun Rev 2011; 10: 624-30.
Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol 2004; 31: 514-9.
Miga A, Masters S, Gonzalez M, Noelle RJ. The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunol Invest 2000; 29: 111-4.
Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207-19.
2010; 34
2000; 29
2005; 174
2002; 132
2006; 11
2008; 38
1993; 64
2008; 58
2011; 10
2011; 32
1961; 190
2001; 44
2003; 33
2009; 33
2004; 31
2007; 179
2007; 315
2000; 15
2002; 168
2004; 37
2002; 46
2002; 21
2004; 172
1994; 12
2008; 67
2003; 27
2001; 2
2003; 60
2009; 38
Singer‐Sam J (e_1_2_6_13_2) 1993; 64
e_1_2_6_31_2
e_1_2_6_30_2
e_1_2_6_18_2
e_1_2_6_19_2
Komura K (e_1_2_6_10_2) 2004; 31
e_1_2_6_12_2
e_1_2_6_11_2
e_1_2_6_16_2
e_1_2_6_17_2
e_1_2_6_14_2
e_1_2_6_15_2
e_1_2_6_20_2
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_29_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_21_2
e_1_2_6_28_2
e_1_2_6_27_2
e_1_2_6_26_2
e_1_2_6_25_2
References_xml – reference: Lu Q, Kaplan M, Ray D, Ray D, Zacharek S, Gutsch D, et al. Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus. Arthritis Rheum 2002; 46: 1282-91.
– reference: Cipriani P, Marrelli A, Liakouli V, Di Benedetto P, Giacomelli R. Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmun Rev 2011; 10: 641-6.
– reference: Cerutti A, Puga I, Cols M. Innate control of B cell responses. Trends Immunol 2011; 32: 202-11.
– reference: Hellman A, Chess A. Gene body-specific methylation on the active X chromosome. Science 2007; 315: 1141-3.
– reference: Bosello S, De Luca G, Tolusso B, Lama G, Angelucci C, Sica G, et al. B cells in systemic sclerosis: a possible target for therapy. Autoimmun Rev 2011; 10: 624-30.
– reference: Lyon MF. Gene action in the X-chromosome of the mouse (mus musculus L.). Nature 1961; 190: 372-3.
– reference: Robertson KD. DNA methylation and chromatin: unraveling the tangled web. Oncogene 2002; 21: 5361-79.
– reference: Chang SC, Tucker T, Thorogood NP, Brown CJ. Mechanisms of X-chromosome inactivation. Front Biosci 2006; 11: 852-66.
– reference: Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004; 37: 457-67.
– reference: Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009; 38: 369-74.
– reference: Miga A, Masters S, Gonzalez M, Noelle RJ. The role of CD40-CD154 interactions in the regulation of cell mediated immunity. Immunol Invest 2000; 29: 111-4.
– reference: Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207-19.
– reference: Valentini G, Romano MF, Naclerio C, Bisogni R, Lamberti A, Turco MC, et al. Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients. J Autoimmun 2000; 15: 61-6.
– reference: Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus inducing drugs. J Immunol 2005; 174: 6212-9.
– reference: Komura K, Sato S, Hasegawa M, Fujimoto M, Takehara K. Elevated circulating CD40L concentrations in patients with systemic sclerosis. J Rheumatol 2004; 31: 514-9.
– reference: Komura K, Fujimoto M, Yanaba K, Matsushita T, Matsushita Y, Horikawa M, et al. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse. Ann Rheum Dis 2008; 67: 867-72.
– reference: Kawai M, Masuda A, Kuwana M. A CD40-CD154 interaction in tissue fibrosis. Arthritis Rheum 2008; 58: 3562-73.
– reference: Chow JC, Brown CJ. Forming facultative heterochromatin: silencing of an X chromosome in mammalian females. Cell Mol Life Sci 2003; 60: 2586-603.
– reference: Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001; 44: 735-6.
– reference: Singer-Sam J, Riggs AD. X chromosome inactivation and DNA methylation. EXS 1993; 64: 358-84.
– reference: Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME. The immunobiology of systemic sclerosis. Semin Arthritis Rheum 2008; 38: 132-60.
– reference: Cron RQ. CD154 transcriptional regulation in primary human CD4 T cells. Immunol Res 2003; 27: 185-202.
– reference: Sakkas LI, Xu B, Arlett CM, Lu S, Jimenez SA, Platsoucas CD. Oligoclonal T cell expansion in the skin of patients with systemic sclerosis. J Immunol 2002; 168: 3649-59.
– reference: Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J Immunol 2004; 172: 3652-61.
– reference: Hewagama A, Richardson B. The genetics and epigenetics of autoimmune diseases. J Autoimmun 2009; 33: 3-11.
– reference: Fukasawa C, Kawaguchi Y, Harigai M, Sugiura T, Takagi K, Kawamoto M, et al. Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40-CD154 in the phenotype of SSc fibroblasts. Eur J Immunol 2003; 33: 2792-800.
– reference: Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881-922.
– reference: Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B, et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007; 179: 6352-8.
– reference: Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001; 2: 777-80.
– reference: Richardson B. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 2002; 132: 2401-5.
– volume: 38
  start-page: 132
  year: 2008
  end-page: 60
  article-title: The immunobiology of systemic sclerosis
  publication-title: Semin Arthritis Rheum
– volume: 12
  start-page: 881
  year: 1994
  end-page: 922
  article-title: The CD40 antigen and its ligand
  publication-title: Annu Rev Immunol
– volume: 64
  start-page: 358
  year: 1993
  end-page: 84
  article-title: X chromosome inactivation and DNA methylation
  publication-title: EXS
– volume: 33
  start-page: 3
  year: 2009
  end-page: 11
  article-title: The genetics and epigenetics of autoimmune diseases
  publication-title: J Autoimmun
– volume: 10
  start-page: 641
  year: 2011
  end-page: 6
  article-title: Cellular players in angiogenesis during the course of systemic sclerosis
  publication-title: Autoimmun Rev
– volume: 132
  start-page: 2401
  year: 2002
  end-page: 5
  article-title: Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer
  publication-title: J Nutr
– volume: 179
  start-page: 6352
  year: 2007
  end-page: 8
  article-title: Demethylation of CD40LG on the inactive X in T cells from women with lupus
  publication-title: J Immunol
– volume: 32
  start-page: 202
  year: 2011
  end-page: 11
  article-title: Innate control of B cell responses
  publication-title: Trends Immunol
– volume: 60
  start-page: 2586
  year: 2003
  end-page: 603
  article-title: Forming facultative heterochromatin: silencing of an X chromosome in mammalian females
  publication-title: Cell Mol Life Sci
– volume: 190
  start-page: 372
  year: 1961
  end-page: 3
  article-title: Gene action in the X‐chromosome of the mouse (mus musculus L.)
  publication-title: Nature
– volume: 33
  start-page: 2792
  year: 2003
  end-page: 800
  article-title: Increased CD40 expression in skin fibroblasts from patients with systemic sclerosis (SSc): role of CD40‐CD154 in the phenotype of SSc fibroblasts
  publication-title: Eur J Immunol
– volume: 34
  start-page: J207
  year: 2010
  end-page: 19
  article-title: Epigenetics and autoimmunity
  publication-title: J Autoimmun
– volume: 172
  start-page: 3652
  year: 2004
  end-page: 61
  article-title: Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells
  publication-title: J Immunol
– volume: 315
  start-page: 1141
  year: 2007
  end-page: 3
  article-title: Gene body‐specific methylation on the active X chromosome
  publication-title: Science
– volume: 27
  start-page: 185
  year: 2003
  end-page: 202
  article-title: CD154 transcriptional regulation in primary human CD4 T cells
  publication-title: Immunol Res
– volume: 29
  start-page: 111
  year: 2000
  end-page: 4
  article-title: The role of CD40‐CD154 interactions in the regulation of cell mediated immunity
  publication-title: Immunol Invest
– volume: 44
  start-page: 735
  year: 2001
  end-page: 6
  article-title: Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma
  publication-title: Arthritis Rheum
– volume: 10
  start-page: 624
  year: 2011
  end-page: 30
  article-title: B cells in systemic sclerosis: a possible target for therapy
  publication-title: Autoimmun Rev
– volume: 37
  start-page: 457
  year: 2004
  end-page: 67
  article-title: The role of CD40‐CD154 interactions in autoimmunity and the benefit of disrupting this pathway
  publication-title: Autoimmunity
– volume: 168
  start-page: 3649
  year: 2002
  end-page: 59
  article-title: Oligoclonal T cell expansion in the skin of patients with systemic sclerosis
  publication-title: J Immunol
– volume: 38
  start-page: 369
  year: 2009
  end-page: 74
  article-title: Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis
  publication-title: Scand J Rheumatol
– volume: 21
  start-page: 5361
  year: 2002
  end-page: 79
  article-title: DNA methylation and chromatin: unraveling the tangled web
  publication-title: Oncogene
– volume: 58
  start-page: 3562
  year: 2008
  end-page: 73
  article-title: A CD40–CD154 interaction in tissue fibrosis
  publication-title: Arthritis Rheum
– volume: 67
  start-page: 867
  year: 2008
  end-page: 72
  article-title: Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight‐skin mouse
  publication-title: Ann Rheum Dis
– volume: 31
  start-page: 514
  year: 2004
  end-page: 9
  article-title: Elevated circulating CD40L concentrations in patients with systemic sclerosis
  publication-title: J Rheumatol
– volume: 15
  start-page: 61
  year: 2000
  end-page: 6
  article-title: Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients
  publication-title: J Autoimmun
– volume: 174
  start-page: 6212
  year: 2005
  end-page: 9
  article-title: Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus inducing drugs
  publication-title: J Immunol
– volume: 2
  start-page: 777
  year: 2001
  end-page: 80
  article-title: Sex differences in autoimmune disease
  publication-title: Nat Immunol
– volume: 11
  start-page: 852
  year: 2006
  end-page: 66
  article-title: Mechanisms of X‐chromosome inactivation
  publication-title: Front Biosci
– volume: 46
  start-page: 1282
  year: 2002
  end-page: 91
  article-title: Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus
  publication-title: Arthritis Rheum
– ident: e_1_2_6_3_2
  doi: 10.1038/ni0901-777
– ident: e_1_2_6_24_2
  doi: 10.1093/jn/132.8.2401S
– ident: e_1_2_6_21_2
  doi: 10.1002/eji.200324088
– ident: e_1_2_6_28_2
  doi: 10.4049/jimmunol.174.10.6212
– ident: e_1_2_6_25_2
  doi: 10.1016/j.jaut.2009.03.007
– ident: e_1_2_6_2_2
  doi: 10.1016/j.autrev.2011.04.013
– ident: e_1_2_6_5_2
  doi: 10.4049/jimmunol.168.7.3649
– ident: e_1_2_6_18_2
  doi: 10.1002/1529-0131(200103)44:3<735::AID-ANR125>3.0.CO;2-F
– ident: e_1_2_6_11_2
  doi: 10.1136/ard.2007.073387
– ident: e_1_2_6_22_2
  doi: 10.1002/art.23994
– ident: e_1_2_6_29_2
  doi: 10.4049/jimmunol.172.6.3652
– ident: e_1_2_6_14_2
  doi: 10.2741/1842
– volume: 64
  start-page: 358
  year: 1993
  ident: e_1_2_6_13_2
  article-title: X chromosome inactivation and DNA methylation
  publication-title: EXS
– ident: e_1_2_6_30_2
  doi: 10.1080/03009740902758875
– ident: e_1_2_6_26_2
  doi: 10.1016/j.jaut.2009.12.006
– ident: e_1_2_6_27_2
  doi: 10.1002/art.10234
– ident: e_1_2_6_16_2
  doi: 10.1038/sj.onc.1205609
– ident: e_1_2_6_15_2
  doi: 10.1126/science.1136352
– ident: e_1_2_6_23_2
  doi: 10.3109/08820130009062292
– volume: 31
  start-page: 514
  year: 2004
  ident: e_1_2_6_10_2
  article-title: Elevated circulating CD40L concentrations in patients with systemic sclerosis
  publication-title: J Rheumatol
– ident: e_1_2_6_4_2
  doi: 10.1016/j.semarthrit.2007.10.010
– ident: e_1_2_6_17_2
  doi: 10.4049/jimmunol.179.9.6352
– ident: e_1_2_6_7_2
  doi: 10.1016/j.it.2011.02.004
– ident: e_1_2_6_20_2
  doi: 10.1080/08916930400002386
– ident: e_1_2_6_6_2
  doi: 10.1016/j.autrev.2011.04.016
– ident: e_1_2_6_31_2
  doi: 10.1007/s00018-003-3121-9
– ident: e_1_2_6_8_2
  doi: 10.1146/annurev.iy.12.040194.004313
– ident: e_1_2_6_9_2
  doi: 10.1006/jaut.2000.0387
– ident: e_1_2_6_12_2
  doi: 10.1038/190372a0
– ident: e_1_2_6_19_2
  doi: 10.1385/IR:27:2-3:185
SSID ssj0002353
ssj0000970605
Score 2.4226353
Snippet Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be...
Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the...
Objective Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2338
SubjectTerms Adult
Biological and medical sciences
CD4-Positive T-Lymphocytes - immunology
CD40 Ligand - genetics
Chromosomes
Deoxyribonucleic acid
Disease Susceptibility
Diseases of the osteoarticular system
DNA
DNA methylation
DNA Methylation - genetics
DNA Methylation - immunology
Female
Gene Expression Regulation
Humans
Lymphocytes
Male
Medical research
Medical sciences
Middle Aged
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Scleroderma, Systemic - genetics
Scleroderma, Systemic - immunology
Sex Factors
Title DNA demethylation of CD40L in CD4+ T cells from women with systemic sclerosis: A possible explanation for female susceptibility
URI https://api.istex.fr/ark:/67375/WNG-VW2ZXKC4-C/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fart.34376
https://www.ncbi.nlm.nih.gov/pubmed/22231486
https://www.proquest.com/docview/1517117747
https://www.proquest.com/docview/1022839890
https://www.proquest.com/docview/1534837304
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLamISFeuF8CozIIoUkoXRo7F8NT1TEGgz6gjVUIybITW6pW0mpppY0X_jrn2EmqooEQb5FyHMUn5zv-bJ98JuQFL0Wei5yFNrc25ADtUGvGQpZHhVAJ45mv8h2nhyf8wySZbJE37b8wXh-iW3BDZLh8jQBXut5bi4aCZ_uMAz4g_2KtFhKiz2vpqJg1CpS48p-IQasqFMV7XcuNsegauvUCayNVDe6x_lyLq4jnJo91A9HBLfKt7YKvPznrr5a6X_z4Td3xP_t4m9xsCCod-oi6Q7ZMdZdc_9Rswd8jP_fHQ1oaPHn60tfR0bmlo30efaTTCi9e0WOK-wE1xX9XqNN4oLjeS71s9LSgNTwaXDKtX9MhXcwRlzNDzcVipvzqJAUuTa35DsMXrVe1q71xZbyX98nJwdvj0WHYnOIQFjzhaVgCR4m15joRNiph7p6n2lrNVJYmJo5tkrJBKVQcKWCiQqmBYSmwzsREg8IIJtgDsl3NK_OI0KJwhDNTJcyCYOgVpoSEZYVV0MZkeUB22-8pi0biHE_amEkvzhxLcKh0Dg3I88504XU9rjJ66YKis1DnZ1gIlyXydPxOfjmNv06ORlyOAtLbiJquAerdZxHPArLThpFskkQtgWxluGeOt591twHe-I1UZeYrsHH6RCIX0V9sAFI5g1TNA_LQh-j6BYD-wYwXurLrAu3PnZUwgXIXj__d9Am5AQSyKV_eIdvL85V5CiRtqXuAxvdHPYfJX7qnNx0
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1db9MwFLWmTQJexjcExjAI0CSULo2dDyPxULWMjnZ9QB2reDFOYkvVurRaWrHywh_ir_CfuLaTVEUD8bIH3iLlpop9fa_PdU_ORegFzVgcs5i4KlbKpRDabpIQ4pLYS5kICI0sy3cQdo_ph1Ew2kA_qm9hrD5EfeCmI8Pkax3g-kB6f6UaClPbIBQCpKRU9uTyKxRsxdvDDnj3pe8fvBu2u27ZU8BNaUBDN4Md008SmgRMeRlUknGYKJUQEYWB9H0VhKSZMeF7AnARE6IpSQgYKJBeM5WMaOklSPhbuoO4VurvfFyJVYFV2beNuiRgzUrHyPP361dd2_22tCMvNBtTFOAQZTtpXAZ115Gz2foObqKf1aRZxstpYzFPGum33_Qk_5dZvYW2SwyOWzZobqMNmd9B145KlsFd9L0zaOFM6ubaS0sVxFOF2x3q9fE41xev8RDrvzwKrD_PwUbGAusjbWyVsccpLuCnwQfj4g1u4dlUp56JxPJiNhH2ABZDuYCVPIMdGheLwtCLDFN5eQ8dX8nw76PNfJrLhwinqcHUkcig0AN0wWQGOVkxJeAZGcUO2qsWEE9LFXfdTGTCrf60z8GB3DjQQc9r05mVLrnM6JVZhbWFOD_VXL8o4CeD9_zTif951GtT3nbQ7toyrR_Qkv6RRyMH7VTrlpd5sOCAJyNNC9C3n9W3IYNpH4lcThdgYySYWMy8v9hA1ogJ7EbUQQ9sTKxeABAuFPUwlD2zsv88WA41orl49O-mT9H17vCoz_uHg95jdAPwcsnW3kGb8_OFfAKYdJ7smlSA0ZerjpJfhC-Tag
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1db9MwFLWmTZp4YXyTMYZBgCahdGnsfBiJh6qhbHRUCG2s4sU4iS1VK2m1tGLlhR_EX-FHcW0nqYoG4mUPvEXKTRX7-l6f656ci9BTmrM4ZjFxVayUSyG03TQlxCWxlzEREBpZlu8gPDihb4fBcA39qL-FsfoQzYGbjgyTr3WAT3O1vxQNhZltEQrxUTEq-3LxFeq18tVhAs595vu918fdA7dqKeBmNKChm8OG6acpTQOmvBwKyThMlUqJiMJA-r4KQtLOmfA9AbCICdGWJAQIFEivnUlGtPIS5PsNGnpM94lIPiy1qsCqattGXRKwdi1j5Pn7zauubH4b2o8XmowpSvCHso00LkO6q8DZ7Hy9LfSznjNLeDlrzWdpK_v2m5zkfzKpN9D1CoHjjg2Zm2hNFrfQ5ruKY3AbfU8GHZxL3Vp7YYmCeKJwN6HeER4V-uIFPsb6D48S649zsBGxwPpAG1td7FGGS_hpcMGofIk7eDrRiWcssbyYjoU9fsVQLGAlv8D-jMt5achFhqe8uINOrmT4d9F6MSnkfYSzzCDqSORQ5gG2YDKHjKyYEvCMjGIH7dXrh2eVhrtuJTLmVn3a5-BAbhzooCeN6dQKl1xm9NwswsZCnJ9ppl8U8NPBG_7x1P807Hcp7zpod2WVNg9oQf_Io5GDduply6ssWHJAk5EmBejbj5vbkL-0j0QhJ3OwMQJMLGbeX2wgZ8QE9iLqoHs2JJYvAPgWSnoYyp5Z2H8eLIcK0Vxs_7vpI7T5Punxo8NB_wG6BmC5omrvoPXZ-Vw-BEA6S3dNIsDo81UHyS8kUpIZ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=DNA+demethylation+of+CD40L+in+CD4%2B+T+cells+from+women+with+systemic+sclerosis%3A+A+possible+explanation+for+female+susceptibility&rft.jtitle=Arthritis+and+rheumatism&rft.au=Lian%2C+XiaoRi&rft.au=Xiao%2C+Rong&rft.au=Hu%2C+Xinhong&rft.au=Kanekura%2C+Takuro&rft.date=2012-07-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0004-3591&rft.eissn=1529-0131&rft.volume=64&rft.issue=7&rft.spage=2338&rft.epage=2345&rft_id=info:doi/10.1002%2Fart.34376&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_VW2ZXKC4_C
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-3591&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-3591&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-3591&client=summon